Valuation
- Market cap
- 68,257,000
- Revenue TTM
- $0
- Net income TTM
- $-4,000,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 9,005
- Avg volume
- 3,914
- Day's range
- $3.30 – $4.00
- Shares out
- 19,502,000
- Stochastic %K
- 2%
- Beta
- -0.12
- Analysts
- Sell
- Price target
- $28.60
Company profile
Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
- Industry
- Consulting Services
- Sector
- Industrials
- Phone
- 310 666 0750
- Website
- https://nordicuspartners.com
- Address
- 280 South Beverly Dr, Suite 505, Beverly Hills, United States
Latest news
No headlines yet.
